News/ News/ R&D Angelini and Arvelle create neurology player with $960m merger Richard Staines Angelini Pharma, cenobamate, M&A, mental health, neurology 0 Comment There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Share X Angelini and Arvelle create neurology player with $960m merger https://pharmaphorum.com/news/angelini-and-arvelle-create-neurology-player-with-960m-merger/
Angelini Pharma, cenobamate, M&A, mental health, neurology
0 Comment
